drugset / Trial / NCT01033084

Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder

NCT01033084 ↗

RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether transcranial direct current stimulation is an effective treatment for major depression, when compared (and combined) to sertraline and placebo.

Timeline

Start
2009-12
Primary completion
2011-12
Completion
2011-12

Outcome

Met primary endpoint

paper At the main end point, there was a significant difference in Montgomery-Asberg depression rating scale scores PMID 23389323 ↗

paper the combined treatment group (sertraline/active tDCS) vs sertraline only (mean difference, 8.5 points; 95% CI, 2.96 to 14.03; P = .002) PMID 23389323 ↗

paper In MDD, the combination of tDCS and sertraline increases the efficacy of each treatment. PMID 23389323 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 50 mg —